GOAI
Eva Live, Inc.4.0000
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
125.37MP/E (TTM)
15.38Basic EPS (TTM)
0.26Dividend Yield
0%Recent Filings
8-K
EVA launches AI quoting beta
EVA Live launched Fast Quote Direct™, an AI quoting engine targeting online lead generation, in beta on February 24, 2026, at fastquotedirect.com. Building on NeuroServer, it automates consumer quoting across services like insurance and home repair, slashing acquisition costs while boosting conversions. Beta tests with partners precede phased 2026 rollout. Forward-looking statements carry risks.
8-K
Secures $7M funding via note
Eva Live entered a securities purchase agreement on February 23, 2026, with Streeterville Capital for a secured convertible note of $7.56M principal (8% OID), netting $7.0M gross proceeds for working capital and business goals. Closing awaits shareholder approval via information statement; note matures in 24 months at 8% interest, convertible at 87% of 10-day VWAP (floor $0.90), secured by all assets. Investor holds 24-month option for $4.32M more. Dilution risk looms large.
8-K
Nasdaq approval granted
Eva Live secured Nasdaq Capital Market listing approval on February 17, 2026, paving the way for its common stock debut. The filing coincides with the NeuroServer web app launch, showing strong enterprise adoption post-beta and up to 40% ROI gains for clients. Management eyes it as 2026's revenue driver. Forward-looking claims carry risks per SEC filings.
8-K
Nasdaq listing approved
Eva Live secured Nasdaq Capital Market listing approval on January 29, 2026, fueling its shift to commercializing the NeuroServer AI ad platform after years of development. The company withdrew its S-1 filing for capital flexibility and eyes a share repurchase program pending board nod. Nasdaq uplisting done. Team expansions position it for rapid sales scaling amid global ad market growth.
8-K
Nasdaq approval; NeuroServe launches
Eva Live secured Nasdaq Capital Market listing approval on January 29, 2026, boosting visibility for its AI ad tech push. The company launched NeuroServe, a real-time AI platform to optimize campaigns, cut errors, and lift ad spend returns—after two years' development and 2025 beta tests. NeuroServe targets core revenue. Management eyes it as top seller by 2026 end.
AEVA
Aeva Technologies, Inc.
14.02-0.35
ARAI
Arrive AI Inc.
3.29+0.05
BLIV
BeLive Holdings
3.39-0.06
DSP
Viant Technology Inc.
11.80+0.33
HPAI
Helport AI Limited
4.08-0.30
PGY
Pagaya Technologies Ltd.
22.31+0.85
RAMP
LiveRamp Holdings, Inc.
29.82+0.61
RZLV
Rezolve AI PLC
2.97+0.65
TUYA
Tuya Inc.
2.19+0.02
YQAI
YOUNEEQAI TECHNICAL SVCS INC
0.52+0.00